How do brain tumors grow and stop responding to treatment?
Despite decades of research, brain tumors remain one of the most lethal cancer types. The greatest challenge is that no curative treatment exists, and all patients eventually develop resistance against the limited amount of treatment options that are currently available.
Our research group aims to uncover the mechanisms by which brain tumor cells become resistant to treatment. The goal is to translate these findings into new strategies that more effectively and specifically kill cancer cells.
We apply genomic, functional genetics and computational approaches to explore these questions in clinical samples and preclinical models, which include cell lines and organoids derived from patients. Our overall goal is to identify and validate novel therapeutic strategies that extend the life of patients diagnosed with a malignant brain tumor.
Verónica Rendo is a researcher in neurology with a focus on brain tumors at the Department of Immunology, Genetics, and Pathology at Uppsala University. She completed her postdocotoral research at the Dana-Farber Cancer Institute at Harvard Medical School and The Broad Institute of MIT and Harvard. In 2025, she became an independent group leader and Beijer Researcher at the Beijer Laboratory for gene and neurological science.